What is the immune cell therapy process of Duomu Health?

Cellular immunity is to collect human autoimmune cells, after in vitro culture, so that their number increases thousands of times, the targeted killing function is enhanced, and then infused back into the human body to kill pathogens, cancer cells, mutant cells in blood and tissues, break immune tolerance, activate and enhance the body's immunity, and take into account the dual effects of ** and health care.

At present, the main methods of making immune cells are: factor-induced killer cells (CIK)**, dendritic cells (DC)**, API biological immunity**, DC+CIK cells**, natural killer cells (NK)**, DC-T cells**, etc., among them, Japan has a significant effect on NK** and DC-T cell immune **** tumors.

1. Effective ** tumors.

With the stored immune cells, it can effectively kill cancer cells, combined with advanced CAR-T cell immunity** technology, infused back into the body, such as nanotar can remove cancer cells in the body, control the development of cancer, and achieve multiple goals such as prolonging the survival of slag mold and improving the quality of life.

2. Improve the body's immunity.

The stored young, well-functioning immune cells are planted into the body, and these immune cells continue to proliferate in the body, replacing the aging immune cells, thereby improving the body's immunity and reducing the occurrence of various diseases.

3. Be prepared for precise ** various diseases.

With the rapid development of medical standards and the continuous improvement of human ability to modify and utilize cells, it is expected that the stored immune cell "seeds" will be used in the future to tailor more and more accurate products for reservoirs for various major diseases**.

Cellular immunity** slag type is used for a variety of solid tumors such as Zichai, including malignant melanoma, prostate cancer, kidney cancer, bladder cancer, ovarian cancer, colon cancer, rectal cancer, breast cancer spine, cervical cancer, lung cancer, laryngeal cancer, nasopharyngeal cancer, pancreatic cancer, liver cancer, gastric cancer and other solid tumor surgery.

Cellular immunity can also be used for multiple myeloma, B lymphoma and leukemia and other hematologic malignancies, and can also be used for the further consolidation of the above tumors for most of the adapted populations of cellular immunity**, so as to prolong survival, improve quality of life and inhibit tumor progression.

However, cellular immunity** is not indicated for patients with T-cell lymphoma, long-term immunosuppressive drugs after organ transplantation, and patients with autoimmune diseases who are taking immunosuppressive drugs.

Compared with surgery, radiotherapy, and chemotherapy, the cellular immunity proposed by Duomu Health is more meaningful for cancer, and the Japanese cellular immunity is aimed at how to prevent malignant tumors, and its main principle is to isolate the monocytes in the peripheral blood of patients (a type of immune cells) in vitro, and after specific antigen action and laboratory culture, they have the ability to specifically kill tumors, and at the same time expand the cells to a certain number in vitro and then infuse them back into the body. Killing those tumor cells that are invisible to the naked eye, so as to prevent tumor metastasis, to a certain extent, solves the serious problem of poor immunity and low quality of life after chemotherapy and radiotherapy, and because the mechanism of autologous cellular immunity can improve the patient's immunity, it can greatly delay the survival time of patients to a certain extent.

It has a significant effect on cancer, improving the quality of life of patients and reducing tumors.